Clotting Factor VIII
Coexistence of Thrombophilic Factors and Hemophilia – A Blessing in Disguise?
Pfizer, Sangamo Dose First Hemophilia A Patient in Phase 3 with Gene Therapy Candidate
Sangamo’s Shares Goes up after the Announcement of Investigational Hemophilia A Gene Therapy Results
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence